Cargando…

Corrigendum: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway

Detalles Bibliográficos
Autores principales:	Cao, Hanbo, Li, Wenjun, Zhou, Yizhou, Tan, Renxiang, Yang, Yue, Zhou, You, Guo, Qinglong, Zhao, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777436/ https://www.ncbi.nlm.nih.gov/pubmed/31608242 http://dx.doi.org/10.3389/fonc.2019.00990

Ejemplares similares

Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway
por: Cao, Hanbo, et al.
Publicado: (2019)

Retraction: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway
Publicado: (2020)

Wogonin reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12-CXCR4/7 axis in bone marrow microenvironment
por: Cao, Hanbo, et al.
Publicado: (2020)

CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy
por: Mezzapelle, Rosanna, et al.
Publicado: (2022)

CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment
por: Giallongo, Cesarina, et al.
Publicado: (2022)

Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment
por: Tan, Ping, et al.
Publicado: (2018)

Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer
por: ZHU, XIAOLI, et al.
Publicado: (2016)

CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer
por: Guo, Jun-Chao, et al.
Publicado: (2016)

Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
por: Han, Zhi-Jian, et al.
Publicado: (2021)

CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target
por: Zhang, Wen, et al.
Publicado: (2020)

Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
por: Wei, Libin, et al.
Publicado: (2017)

CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment
por: Würth, Roberto, et al.
Publicado: (2014)

Corrigendum: Role of the CXCL13/CXCR5 axis in autoimmune diseases
por: Pan, Zijian, et al.
Publicado: (2022)

CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
por: Naumann, Ulrike, et al.
Publicado: (2010)

Triggering apoptosis by oroxylin A through caspase-8 activation and p62/SQSTM1 proteolysis
por: Zhao, Yue, et al.
Publicado: (2019)

CXCL12/SDF-1 and CXCR4
por: Nagasawa, Takashi
Publicado: (2015)

Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma
por: Guo, Li, et al.
Publicado: (2011)

Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer
por: Huang, Yu, et al.
Publicado: (2013)

CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
por: Werner, Thomas Artur, et al.
Publicado: (2018)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020)

Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome
por: Zhou, Wei, et al.
Publicado: (2017)

CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
por: Wu, Xia, et al.
Publicado: (2023)

Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53
por: Qiao, Chen, et al.
Publicado: (2016)

The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities
por: Patterson, Shaun David, et al.
Publicado: (2023)

Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma
por: Kasashima, Hiroaki, et al.
Publicado: (2017)

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications
por: Yang, Yaru, et al.
Publicado: (2023)

Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory Bowel Disease
por: Werner, Lael, et al.
Publicado: (2013)

Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7
por: Goïta, Aïssata Aimée, et al.
Publicado: (2022)

Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
por: Collins, Paul J., et al.
Publicado: (2017)

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis
por: Dunbar, Andrew J., et al.
Publicado: (2023)

Profiling of Cxcl12 Receptors, Cxcr4 and Cxcr7 in Murine Testis Development and a Spermatogenic Depletion Model Indicates a Role for Cxcr7 in Controlling Cxcl12 Activity
por: Westernströer, Birgit, et al.
Publicado: (2014)

On-Chip Organoid Formation to Study CXCR4/CXCL-12 Chemokine Microenvironment Responses for Renal Cancer Drug Testing
por: Ozcelik, Adem, et al.
Publicado: (2022)

Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma
por: Liberman, Julie, et al.
Publicado: (2012)

CXCR4/CXCL12 expression and signalling in kidney cancer
por: Schrader, A J, et al.
Publicado: (2002)

CXCL12-CXCR4 axis in feline mammary carcinoma
por: Ferreira, Fernando
Publicado: (2017)

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022)

Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells
por: Wang, Feixia, et al.
Publicado: (2019)

Expression levels of CXCR4 and CXCL12 in patients with rheumatoid arthritis and its correlation with disease activity
por: Peng, Liping, et al.
Publicado: (2020)

The CXCL8-CXCR1/2 pathways in cancer
por: Liu, Qian, et al.
Publicado: (2016)

CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12
por: Melo, Rita de Cássia Carvalho, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_55ancvbd5krno4da74efhmvgaq